SR17018

CAS No. 2134602-45-0

SR17018( SR17018 | SR-17018 | SR 17018 )

Catalog No. M17433 CAS No. 2134602-45-0

SR17018 is an mu-opioid-receptor (MOR) agonist, binding with GTPγS, with an EC50 of 97 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 58 In Stock
2MG 32 In Stock
5MG 51 In Stock
10MG 85 In Stock
25MG 179 In Stock
50MG 299 In Stock
100MG 475 In Stock
200MG 678 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SR17018
  • Note
    Research use only, not for human use.
  • Brief Description
    SR17018 is an mu-opioid-receptor (MOR) agonist, binding with GTPγS, with an EC50 of 97 nM.
  • Description
    SR17018 is an mu-opioid-receptor (MOR) agonist with an EC50 of 97 nM.
  • In Vitro
    SR17018 is an mu-opioid-receptor (MOR) agonist, binding with GTPγS, with an EC50 of 97 nM. SR17018 shows no obvious effect on inducing βarrestin2 recruitment to the MOR at below 10 μM. SR17018 promotes signaling through G proteins or βarrestin2.
  • In Vivo
    ——
  • Synonyms
    SR17018 | SR-17018 | SR 17018
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    CETP
  • Recptor
    μ-opioid receptor
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    2134602-45-0
  • Formula Weight
    410.72
  • Molecular Formula
    C19H18Cl3N3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 6.4 mg/mL. 15.58 mM;
  • SMILES
    Clc3cc4NC(=O)N(C2CCN(Cc1ccc(Cl)cc1)CC2)c4cc3Cl
  • Chemical Name
    5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Schmid CL,etal.Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics.Cell. 2017 Nov 16;171(5):1165-1175.
molnova catalog
related products
  • BMS-212122

    BMS-212122 (UNII-0Z473OO6GB) is a potent inhibitor of microsomal triglyceride transfer protein (MTP) and has shown hypolipidemic effects in animal studies.BMS-212122 significantly reduced lipid content and monocyte-derived (CD68+) cells in atherosclerotic plaques.

  • TAP-311

    TAP-311 is a novel potent and selective CETP inhibitor with plasma IC50 of 62 nM.

  • Obicetrapib

    Obicetrapib (AMG-899, TA-8995, DEX-001) is a potent, ora cholesteryl ester transfer protein (CETP) inhibitor for treatment of dyslipidaemia.